PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16633175-4	2006	Here, we report the reconstruction of a frontal bone defect using heparin together with bovine type I collagen, hyaluronic acid, and fibrin as vehicles for BMP-2.	Hyaluronic Acid	112-127	bone morphogenetic protein 2	Bos taurus	156-161	
23871940-0	2013	The influence of collagen and hyaluronan matrices on the delivery and bioactivity of bone morphogenetic protein-2 and ectopic bone formation.	Hyaluronic Acid	30-40	bone morphogenetic protein 2	Bos taurus	85-113	
23871940-6	2013	We compared a thiol-modified hyaluronan (Glycosil ) hydrogel that exhibits a low burst followed by a sustained release of BMP-2 to a collagen sponge for the delivery of three different doses of BMP-2, the bioactivities of released BMP-2 and ectopic bone formation.	Hyaluronic Acid	29-39	bone morphogenetic protein 2	Bos taurus	122-127	
23871940-7	2013	Analysis of bone formation by micro-computed tomography revealed that low burst followed by sustained release of BMP-2 from a hyaluronan hydrogel induced up to 456% more bone compared to a BMP-2 dose-matched collagen sponge that has a high burst and sustained release.	Hyaluronic Acid	126-136	bone morphogenetic protein 2	Bos taurus	113-118	
23871940-9	2013	This highlights the therapeutic potential of hydrogels, particularly hyaluronan-based, for the delivery of BMP-2 for the treatment of bone defects and may help abrogate the adverse clinical effects associated with high dose growth factor use.	Hyaluronic Acid	69-79	bone morphogenetic protein 2	Bos taurus	107-112